Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals
Clinical trial NCT06762730 · RECRUITING
Trial details
- NCT number
- NCT06762730
- Sponsor
- Hadassah Medical Organization
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-09
- Primary completion
- 2028-12-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.